Ceros Financial Services announced that Ceros Capital Markets, its investment banking division, has completed a $7.5 million Series A round for Wesper, which has developed the first clinical-grade FDA cleared platform to bring the full cycle of sleep therapy to home users.

Wesper, previously known as Tatch, is a state-of-the-art diagnostic and outcome management patch, that provides high-quality sleep analysis in maximal comfort. Wesper brings together advances in printed electronics, machine learning and wearable technology to make sleep medicine more seamless and accurate than ever before. 

Ceros Financial Services Arranges $7.5 Million Financing For Wesper

Description

Company Information

Related People

Ceros Financial Services Arranges $7.5 Million Financing For Wesper

Description

.css-1v6jzuu{--tw-text-opacity:1;color:rgba(75, 85, 99, var(--tw-text-opacity));}Company Information

Related People

Company Information